Duncker Streett & Co’s Virtus Biotech ETF BBP Stock Holding History

Duncker Streett & Co’s Portfolio BBP Stock Details BBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-534	Closed	-$30.2K	–	489
2024 Q1	$30.2K	Hold	534	–	–	0.01%	348
2023 Q4	$31K	Hold	534	–	–	0.01%	337
2023 Q3	$26.7K	Hold	534	–	–	0.01%	340
2023 Q2	$28.1K	Hold	534	–	–	0.01%	337
2023 Q1	$26.3K	Hold	534	–	–	0.01%	335
2022 Q4	$26.3K	Buy	+534	New	+$25.5K	0.01%	347

Other funds holding BBP

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

IFG

Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Duncker Streett & Co's BBP Position: Q2 2024 in Review

Duncker Streett & Co sold out of Virtus Biotech ETF (BBP) in Q2 2024, closing a stake of 534 shares — an estimated $30.2K sold.

Duncker Streett & Co first reported a position in BBP in Q4 2022 and held it in 6 quarters. The position peaked at $31K in Q4 2023. 13 funds tracked by Wall St. Rank hold BBP as of Q2 2024.

Duncker Streett & Co reported no remaining Virtus Biotech ETF position as of Q2 2024 after selling out during the quarter.
Duncker Streett & Co sold 534 Virtus Biotech ETF shares in Q2 2024, an estimated $30.2K.
Duncker Streett & Co first reported a position in Virtus Biotech ETF in Q4 2022 and held it in 6 quarters.
Duncker Streett & Co's Virtus Biotech ETF position peaked at $31K in Q4 2023.
13 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q2 2024.

Based on Duncker Streett & Co's 13F filing for Q2 2024, filed 31 Jul 2024.